| Literature DB >> 24676371 |
Danielle Cristina Tomaz da Silva1, Ana Paula Lima-Leopoldo2, André Soares Leopoldo2, Dijon Henrique Salomé de Campos1, André Ferreira do Nascimento1, Silvio Assis de Oliveira Junior3, Carlos Roberto Padovani4, Antonio Carlos Cicogna1.
Abstract
BACKGROUND: Obesity is a risk factor for many medical complications; medical research has shown that hemodynamic, morphological and functional abnormalities are correlated with the duration and severity of obesity.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24676371 PMCID: PMC3987330 DOI: 10.5935/abc.20130232
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Final body weight (A), adiposity index (B), leptin (C), insulin (D), area under curve (AUC) of intraperitoneal glucose tolerance test (E), systolic blood pressure (SBP) (F) in control (white bars) and obese rats (black bars) after 15 and 30 weeks of treatment. Date are mean ± SD; two-way ANOVA and Bonferroni post hoc test. *p < 0.05 vs control group; # p < 0,05 Ob15 vs Ob30
Figure 2Left ventricle dimensions. Left ventricle (LV) weight (A), and left ventricle weight/tíbia ratio (B) in control (white bars) and obese rats (black bars) after 15 and 30 weeks of treatment. Data are mean ± SD; two-way ANOVA and Bonferroni post hoc test. *p < 0.05 vs control group.
Figure 3Westem bolt analysis of collagen I and III in the heart of control (white bars) and obese rats (black bars) after 15 and 30 weeks of treatment. Blots were scanned. Histographic presentation of collagen I/β-actin (A) and collagen III/β-actin ratios. (B). Data are mean ± SD from different animals per group; two-way ANOVA and Bonferroni post hoc test. *p < 0.05 vc control group; # p < 0,05 Ob15 vs Ob30.